Medicare Enrolled
Dr. Sadiq Altamimi, MD
Neurology · Pomona, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Altamimi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Altamimi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Altamimi
Dr. Sadiq Altamimi is a neurology specialist in Pomona, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Altamimi performed 5,122 Medicare services across 1,944 unique beneficiaries.
Between the years covered by Open Payments, Dr. Altamimi received a total of $27,297 from 88 pharmaceutical and/or device companies across 1470 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Altamimi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 15% volume in CA
$27,297 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,122
Medicare services
Top 15% in CA for neurology
1,944
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~285 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
1,412 | $41 | $75 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
1,343 | $53 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
449 | $92 | $181 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
315 | $46 | $80 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
210 | $81 | $130 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
196 | $42 | $75 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
191 | $34 | $60 |
| Psychological test administration, each additional 30 minutes A technician administers psychological or neuropsychological testing. This code covers each additional 30-minute increment of administration time. |
162 | $29 | $60 |
| New patient office visit, complex (60-74 min) | 142 | $159 | $280 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
115 | $394 | $585 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
107 | $242 | $425 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
97 | $102 | $180 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
97 | $138 | $246 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
88 | $28 | $60 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
63 | $122 | $225 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
54 | $17 | $30 |
| Chemical nerve block injection, 5+ arm/leg muscles Injection of a chemical agent to paralyze five or more muscles in the first extremity treated. |
36 | $149 | $255 |
| Chemical nerve paralysis injection, each additional extremity Injection of a chemical agent to paralyze nerves and muscles in an additional arm or leg. This is billed for each extremity beyond the first one treated. |
32 | $101 | $160 |
| Auditory brainstem response test A test that measures how the brain responds to sound to help diagnose nervous system disorders. The results are interpreted and reported by a medical professional. |
13 | $75 | $125 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$27,297
Total received (2018-2024)
Avg $3,900/year across 7 years
Top 13% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
88
Companies
1,470
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$26,690 (97.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$607 (2.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,361
2023
$5,321
2022
$4,269
2021
$1,910
2020
$1,255
2019
$4,180
2018
$5,002
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,012
UCB, Inc.
$747
PFIZER INC.
$578
Novartis Pharmaceuticals Corporation
$433
Alexion Pharmaceuticals, Inc.
$344
ARGENX US, INC.
$331
ACADIA Pharmaceuticals Inc
$330
Amneal Pharmaceuticals LLC
$209
Lilly USA, LLC
$166
Biogen, Inc.
$166
Otsuka America Pharmaceutical, Inc.
$135
Lundbeck LLC
$119
Eisai Inc.
$111
Alnylam Pharmaceuticals Inc.
$107
Celgene Corporation
$88
Teva Pharmaceuticals USA, Inc.
$73
Genentech USA, Inc.
$53
MDD US Operations, LLC
$50
MITSUBISHI TANABE PHARMA AMERICA, INC.
$46
Grifols USA, LLC
$36
JAZZ PHARMACEUTICALS INC.
$36
Takeda Pharmaceuticals U.S.A., Inc.
$34
EMD Serono, Inc.
$23
Octapharma USA, Inc.
$23
SK Life Science, Inc.
$22
Mallinckrodt Hospital Products Inc.
$22
SCILEX PHARMACEUTICALS INC.
$20
Kyowa Kirin, Inc.
$19
Abbott Laboratories
$17
Aucta Pharmaceuticals, Inc.
$7
Top 3 companies account for 43.6% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$2,084
Alexion Pharmaceuticals, Inc.
$1,793
ABBVIE INC.
$1,643
AbbVie Inc.
$1,590
Teva Pharmaceuticals USA, Inc.
$1,493
Novartis Pharmaceuticals Corporation
$1,355
Biogen, Inc.
$1,310
LivaNova USA, Inc.
$1,273
ACADIA Pharmaceuticals Inc
$1,258
Sunovion Pharmaceuticals Inc.
$1,055
Lilly USA, LLC
$929
Octapharma USA, Inc.
$856
PFIZER INC.
$761
Allergan Inc.
$675
Amneal Pharmaceuticals LLC
$659
ARGENX US, INC.
$589
Allergan, Inc.
$531
Amgen Inc.
$466
Avanir Pharmaceuticals, Inc.
$435
US WorldMeds, LLC
$367
Otsuka America Pharmaceutical, Inc.
$345
SK Life Science, Inc.
$333
Alnylam Pharmaceuticals Inc.
$297
Neurocrine Biosciences, Inc.
$288
Acorda Therapeutics, Inc
$281
Lundbeck LLC
$276
Takeda Pharmaceuticals U.S.A., Inc.
$266
GENZYME CORPORATION
$264
Supernus Pharmaceuticals, Inc.
$250
EMD Serono, Inc.
$248
CSL Behring
$200
Greenwich Biosciences, Inc.
$191
Genentech USA, Inc.
$189
Eisai Inc.
$188
Akcea Therapeutics, Inc.
$139
Biohaven Pharmaceuticals, Inc.
$139
MITSUBISHI TANABE PHARMA AMERICA, INC.
$131
Adamas Pharmaceuticals, Inc.
$119
Mallinckrodt LLC
$110
Avion Pharmaceuticals
$99
Kyowa Kirin, Inc.
$98
Celgene Corporation
$88
Terumo BCT, Inc.
$80
PORTOLA PHARMACEUTICALS, INC.
$79
MDD US Operations, LLC
$75
Abbott Laboratories
$74
JAZZ PHARMACEUTICALS INC.
$71
Assertio Therapeutics, Inc.
$70
Corium, LLC
$68
Boston Scientific Corporation
$65
AbbVie, Inc.
$55
NEUROPACE, INC.
$55
Mitsubishi Tanabe Pharma America, Inc.
$53
Ipsen Biopharmaceuticals, Inc
$52
Impax Laboratories, Inc.
$51
Microtransponder, Inc.
$51
Grifols USA, LLC
$49
Mallinckrodt Enterprises LLC
$48
Xeris Pharmaceuticals, Inc.
$41
Scilex Pharmaceuticals Inc.
$37
Arbor Pharmaceuticals, Inc.
$37
Merz Pharmaceuticals, LLC
$34
Neurelis, Inc.
$33
Biohaven Pharmaceutical Holding Company Ltd.
$31
Sumitomo Pharma America, Inc.
$28
Upsher-Smith Laboratories LLC
$25
CATALYST PHARMACEUTICALS, INC.
$23
Strongbridge US INC.
$23
EISAI INC.
$22
SANOFI-AVENTIS U.S. LLC
$22
Mallinckrodt Hospital Products Inc.
$22
SCILEX PHARMACEUTICALS INC.
$20
GE Healthcare
$20
Sarepta Therapeutics, Inc.
$19
Amylyx Pharmaceuticals, Inc.
$18
Catalyst Pharmaceuticals, Inc.
$17
E.R. Squibb & Sons, L.L.C.
$17
Bayer HealthCare Pharmaceuticals Inc.
$17
GE HEALTHCARE
$16
Cala Health, Inc.
$16
Vertical Pharmaceuticals, LLC
$15
Azurity Pharmaceuticals, Inc.
$15
Janssen Pharmaceuticals, Inc
$14
Egalet US Inc
$13
W. L. Gore & Associates, Inc.
$13
Zogenix Inc.
$13
Zyla Life Sciences, Inc.
$11
Aucta Pharmaceuticals, Inc.
$7
Top 3 companies account for 20.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Austedo XR · BEVYXXA · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · CALA TRIO · CAMBIA · CARDIOFORM Septal Occluder · COMIRNATY · COPAXONE · CREXONT · Cambia · DUOPA · Dhivy · Duopa · Dysport · EMGALITY · EPIDIOLEX · EXONDYS 51 · EXSERVAN · Epidiolex · FABRAZYME · FIRDAPSE · Fintepla · Fycompa · GAMMAGARD · GENERAL PAIN MANAGEMENT · GILENYA · GOCOVRI · Gamunex-C · Gocovri · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LEQEMBI · LYRICA · Leqembi · MAYZENT · MYOBLOC · Mavenclad · Motpoly XR · NAMZARIC · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Neuromodulation Dspsbls and Accs · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · PANZYGA · POMPE - DISEASE · Ponvory · QELBREE · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · RELYVRIO · REXULTI · RNS System · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · Soliris · Spectra Optia · Superion Indirect Decompression System · TECFIDERA · TEGSEDI · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WaveWriter Alpha Prime 16 · XCOPRI · XYWAV · Xadago · Xeomin · ZEPOSIA · ZTLido · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
215
Per 100K population
2.2
County median income
$87,760
Nearest hospital
POMONA VALLEY HOSPITAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Altamimi is a clinical cardiology specialist, with above-average Medicare volume (top 15% in CA), with low-engagement industry engagement in the top 13% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Altamimi experienced with chronic care management, additional 20 min/month?
Based on Medicare claims data, Dr. Altamimi performed 1,412 chronic care management, additional 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Altamimi receive payments from pharmaceutical companies?
Yes. Dr. Altamimi received a total of $27,297 from 88 companies across 1,470 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Altamimi's costs compare to other neurologists in Pomona?
Dr. Altamimi's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Altamimi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Pomona
Browse neurologists in Pomona ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology